November 18, 2022 11:18 AM EST
News Briefing

PaxMed­ica surges af­ter fi­nanc­ing; Mar­i­nus makes Chi­na de­vel­op­ment and sales pact

Drew Armstrong

Executive Editor

Shares of small-cap drug­mak­er PaxMed­ica surged 65% on Fri­day af­ter the com­pa­ny an­nounced a fi­nanc­ing deal worth as much as $20 mil­lion with the in­vest­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

De­spite mixed da­ta in Alzheimer's ag­i­ta­tion, Ax­some will still seek FDA ap­proval

Ideaya inks ADC deal with $75M up­front; Amy­lyx, Gubra to de­vel­op long-act­ing GLP-1

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Up­dat­ed: Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force as CEO de­parts

A service from the Financial Times